Brief: Tevogen Advances Strategic CRO Evaluation To Expand Clinical Research Delivery Capabilities And Drive Revenue Growth
26/03/2026 18:12
March 26 (Reuters) - Tevogen Bio Holdings Inc TVGN.O: TEVOGEN ADVANCES STRATEGIC CRO EVALUATION TO EXPAND CLINICAL RESEARCH DELIVERY CAPABILITIES AND DRIVE REVENUE GROWTH TEVOGEN BIO HOLDINGS: OPPORTUNITY EXPECTED TO CONTRIBUTE MORE THAN $20 MILLION IN ANNUAL REVENUE WHILE SUPPORTING DOUBLE-DIGIT GROWTH BEGINNING NEXT YEAR Source text: ID:nGNX6LC3Ks Further company coverage: TVGN.O ((Reuters.Briefs@thomsonreuters.com;))